LONG-TERM, SUSTAINED SAFETY AND EFFICACY OF REPEAT ONABOTULINUMTOXINA TREATMENT IN MULTIPLE SCLEROSIS PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY

被引：0
|
作者：
Del Popolo, Giulio [1 ]
Panicker, Jalesh [2 ,3 ]
Aliotta, Philip [4 ]
Joshi, Manher [5 ]
Jenckins, Brenda [5 ]
Zheng, Yan [5 ]
Kohan, Alfred [6 ]
机构：
[1] Careggi Univ Hosp, Neurourol Dept, Florence, Italy
[2] Natl Hosp Neurol & Neurosurg, London, England
[3] UCL, Inst Neurol Queen Sq, London, England
[4] Western New York Urol Associates LLC, Cheektowaga, NY USA
[5] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[6] Adv Urol Ctr New York, Bethpage, NY USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
URINARY-INCONTINENCE;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：S3 / S4
页数：2
相关论文
共 50 条
  • [31] Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity
    Chapple, C. R.
    Fowler, C.
    Conn, G.
    Ginsberg, D.
    Lam, W.
    Thompson, C.
    BJU INTERNATIONAL, 2011, 108 : 20 - 20
  • [32] Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity
    Dmochowski, R.
    Ginsberg, D.
    Ethans, K.
    Brin, M.
    Lam, W.
    Haag-Molkenteller, C.
    TOXICON, 2013, 68 : 109 - 110
  • [33] Efficacy of peripheral lidocaine application (neural therapy) in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
    Tamam, Yusuf
    Ozdemir, Hasan Huseyin
    Gedik, Abdullah
    Tamam, Cuneyt
    Nazlikul, Huseyin
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (07) : 1832 - 1838
  • [34] Neural or "Moral" therapy in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
    Ekiz, Timur
    Mezian, Kamal
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (08) : 2973 - 2974
  • [35] Sustained Clinical Efficacy after Repeat Intradetrusor Botulinum Toxin Type A in the Treatment of Neurogenic Detrusor Overactivity
    Png, Keng Siang
    Toh, Khai-Lee
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2010, 39 (02) : 152 - 153
  • [36] LONG TERM REAL LIFE EFFICACY OF ONABOTULINUMTOXINA FOR THE TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY IN A POPULATION USING INTERMITTENT SELF-CATHETERIZATION.
    Joussain, C.
    Popoff, M.
    Phe, V
    Schneider, Even A.
    Falcou, L.
    Chartier-Kastler, E.
    Schurch, B.
    Denys, P.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S422 - S424
  • [37] Intravesical botulinum toxin use in detrusor overactivity: A comparison of long-term outcomes in patients with Multiple Sclerosis and Idiopathic Detrusor Overactivity
    Kealey, J.
    Chan, G.
    Yao, H.
    O'Connell, H.
    Gani, J.
    Parkinson, R.
    Bazo, A.
    EUROPEAN UROLOGY, 2022, 81 : S1052 - S1052
  • [38] Positive outcomes with first onabotuinumtoxinA treatment persist long term with repeat treatments in patients with neurogenic detrusor overactivity
    Dielubanza, Elodi
    Vasavada, Sandip
    BJU INTERNATIONAL, 2017, 120 (03) : E1 - E2
  • [39] Comparative Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Refractory Neurogenic Detrusor Overactivity: An Indirect Treatment Comparison
    Danchenko, Natalya
    Fahrbach, Kyle
    Freitag, Andreas
    Tarpey, Jialu
    Whalen, John
    TOXICON, 2022, 214 : S15 - S15
  • [40] A DOSE-EXPLORATION STUDY OF THE EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY
    Apostolidis, A.
    Mourad, S.
    Thompson, C.
    Yan, X.
    Haag-Molkenteller, C.
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (06) : 926 - 927
12345